Have a personal or library account? Click to login
Uric Acid, Oxidative Stress and Inflammation in Chronic Heart Failure with Reduced Ejection Fraction Cover

Uric Acid, Oxidative Stress and Inflammation in Chronic Heart Failure with Reduced Ejection Fraction

Revista Romana de Medicina de Laborator
Volume 23 (2015): Issue 4 (December 2015)
By: Adriana Iliesiu,  Alexandru Campeanu,  Daciana Marta,  Irina Parvu and  Gabriela Gheorghe  
Open Access
|Dec 2015

References

  1. 1. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003;107(15):1991–7. DOI: 10.1161/01. CIR.0000065637.10517.A0
    Search in Google Scholar
  2. 2. Kittleson MM, St John ME, Bead V, Champion HC, Kasper EK, Russell SD, et al. Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels. Heart 2007;93(3):365–7. DOI: 10.1136/hrt.2006.09084510.1136/hrt.2006.090845186145017322514
    Search in Google Scholar
  3. 3. Cengel A, Turkoglu S, Turfan M, Boyaci B, et al. Serum uric acid levels as a predictor of in-hospital death in patients hospitalized for decompensated heart failure. Acta Cardiologica 2005;60(5):489–92. DOI: 10.2143/AC.60.5.200496910.2143/AC.60.5.200496916261779
    Search in Google Scholar
  4. 4. Sakai H, Tsutamoto T, Tsutsui T, Tanaka T, Ishikawa C, Horie M, et al. Serum level of uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive heart failure. Circ J. 2006;70(8):1006–11. DOI: 10.1253/circj.70.100610.1253/circj.70.100616864933
    Search in Google Scholar
  5. 5. Tamariz L, Harzand A, Palacio A, Verma S, Jones J, Hare J, et al. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congest Heart Fail. 2011;17(1):25–30. DOI: 10.1111/j.1751-7133.2011.00200.x10.1111/j.1751-7133.2011.00200.x21272224
    Search in Google Scholar
  6. 6. Gotsman I, Keren A, Lotan C, Zwas DR. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival. J Card Fail. 2012;18(9):694-701. DOI: 10.1016/j.cardfail.2012.06.52810.1016/j.cardfail.2012.06.52822939038
    Search in Google Scholar
  7. 7. Ashraf M, Samra ZQ. Subcellular distribution of xanthineoxidase during cardiac ischemia and reperfusion: an immunocytochemical study. J Submicrosc Cytol Pathol 1993; 25(2):193–201.
    Search in Google Scholar
  8. 8. Terada LS, Guidot DM, Leff JA, Willingham IR, Hanley ME, Piermattei D, et al. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci USA. 1992;89(8):3362–6. DOI: 10.1073/pnas.89.8.336210.1073/pnas.89.8.3362488671314387
    Search in Google Scholar
  9. 9. Lazzarino G, Raatikainen P, Nuutinen M, Nissinen J, Tavazzi B, Di Pierro D, et al. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery. Circulation. 1994;90(1):291–7. DOI: 10.1161/01.CIR.90.1.29110.1161/01.CIR.90.1.2918026011
    Search in Google Scholar
  10. 10. Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, et al. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 1998;19(12):1814–22. DOI: 10.1053/euhj.1998.118810.1053/euhj.1998.11889886724
    Search in Google Scholar
  11. 11. Anker SD, Leyva F, Poole-Wilson PA, Kox WJ, Stevenson JC, Coats AJ. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart. 1997;78(1):39–43. DOI: 10.1136/hrt.78.1.3910.1136/hrt.78.1.394848629290400
    Search in Google Scholar
  12. 12. Doehner W, Rauchhaus M, Florea VG, Sharma R, Bolger AP, Davos CH, et al. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance. Am Heart J. 2001;141(5):792–9. DOI: 10.1067/mhj.2001.11436710.1067/mhj.2001.11436711320368
    Search in Google Scholar
  13. 13. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008;10(10):933–989. DOI: 10.1016/j.ejheart.2008.08.00510.1016/j.ejheart.2008.08.00518826876
    Search in Google Scholar
  14. 14. Buchmann R, Hasilik A, Van Dyke TE, Lange DE. Amplified Crevicular Leukocyte Activity in Aggressive Periodontal Disease. J Dent Res. 2002. 81(10):716-721. DOI: 10.1177/15440591020810101210.1177/15440591020810101212351672
    Search in Google Scholar
  15. 15. Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res. 2003; 44(4):780-792. DOI: 10.1194/jlr. M200432-JLR20010.1194/jlr
    Search in Google Scholar
  16. 16. Krishnan E. Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010. J Am Heart Assoc. 2014;3(2):e000157. DOI: 10.1161/JAHA.113.00015710.1161/JAHA.113.000157418751424627417
    Search in Google Scholar
  17. 17. Sinan Deveci O, Kabakci G, Okutucu S, Tulumen E, Aksoy H, Baris Kaya E, et al. The association between serum uric acid level and coronary artery disease. Int J Clin Pract. 2010; 64(7):900-7. DOI: 10.1111/j.1742-1241.2009.02263.x10.1111/j.1742-1241.2009.02263.x20584223
    Search in Google Scholar
  18. 18. Duran M, Kalay N, Akpek M, Orscelik O, Elcik D, Ocak A, et al. High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. Angiology. 2012;63(6):448-52. DOI: 10.1177/000331971142686810.1177/000331971142686822096206
    Search in Google Scholar
  19. 19. Gotsman I, Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005;11(32):4145-51. DOI: 10.2174/13816120577491325510.2174/13816120577491325516375736
    Search in Google Scholar
  20. 20. Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, et al. Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2014;16(1):15-24. DOI: 10.1093/eurjhf/hft13210.1093/eurjhf/hft13223933579
    Search in Google Scholar
  21. 21. Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB, Love TE, et al. Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J. 2011;32(6):712-20. DOI: 10.1093/eurheartj/ehq47310.1093/eurheartj/ehq473305620521199831
    Search in Google Scholar
  22. 22. Amin A, Vakilian F, Maleki M. Serum uric acid levels correlate with filling pressures in systolic heart failure. Congest Heart Fail. 2011;17(2):80-4. DOI: 10.1111/j.1751-7133.2010.00205.x10.1111/j.1751-7133.2010.00205.x21449996
    Search in Google Scholar
  23. 23. Zhang YH, Lü R, Zhao XY, Kang LM, Yang YJ, Zhang J. Association of serum uric acid, plasma NT-proBNP, Hs-C reactive protein and invasive hemodynamic parameters in patients with heart failure. Zhonghua Xin Xue Guan Bing Za Zhi. 2009;37(2):126-9.
    Search in Google Scholar
  24. 24. Wojciechowska C, Romuk E, Tomasik A, Skrzep-Poloczek B, Nowalany-Kozielska E, Birkner E, Jache W. Oxidative stress markers and c-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy. Mediators Inflamm. 2014;2014:147040. DOI: 10.1155/2014/14704010.1155/2014/147040
    Search in Google Scholar
  25. 25. Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, et al. Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. Am Heart J. 2002; 143(6):1107-11. DOI: 10.1067/mhj.2002.12212210.1067/mhj.2002.122122
    Search in Google Scholar
  26. 26. Vaduganathan M, Greene SJ, Ambrosy AP, Mentz RJ, Subacius HP, Chioncel O, et al. Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial). Am J Cardiol. 2014;114(11):1713-21. DOI: 10.1016/j.amjcard.2014.09.00810.1016/j.amjcard.2014.09.008
    Search in Google Scholar
  27. 27. Pinelli M, Bindi M, Filardo FP, Moroni F, Castiglioni M. Serum uric acid levels correlate with left ventricular ejection fraction and systolic pulmonary artery pressure in patients with heart failure. [Article in Italian] Recenti Prog Med. 2007;98(12):619-23.
    Search in Google Scholar
  28. 28. Borghi C, Cosentino ER, Rinaldi ER, Cicero AF. Uricaemia and ejection fraction in elderly heart failure outpatients. Eur J Clin Invest. 2014;44(6):573-8. DOI: 10.1111/eci.1227310.1111/eci.12273
    Search in Google Scholar
  29. 29. Hare JM, Mangal B, Brown J, Fisher C Jr, Freudenberger R, Colucci WS, et al. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol. 2008; 51(24):2301-9. DOI: 10.1016/j.jacc.2008.01.06810.1016/j.jacc.2008.01.068
    Search in Google Scholar
  30. 30. Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, et al. Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail. 2014;16(1):15-24. DOI: 10.1093/eurjhf/hft13210.1093/eurjhf/hft132
    Search in Google Scholar
  31. 31. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol. 1998;31(6):1352–6. DOI: 10.1016/S0735-1097(98)00101-610.1016/S0735-1097(98)00101-6
    Search in Google Scholar
  32. 32. Díaz-Vélez CR, García-Casti-eiras S, Mendoza-Ramos E, Hernández-López E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J. 1996;131(1):146-52. DOI: 10.1016/S0002-8703(96)90063-010.1016/S0002-8703(96)90063-0
    Search in Google Scholar
  33. 33. Reina-Couto M, Carvalho J, Valente MJ, Vale L, Afonso J, Carvalho F, et al. Impaired resolution of inflammation in human chronic heart failure. Eur J Clin Invest. 2014; 44(6):527-38. DOI: 10.1111/eci.1226510.1111/eci.1226524673112
    Search in Google Scholar
  34. 34. Wilson Tang WH, Wu Y, Mann S, Pepoy M, Shrestha K, Borowski AG, et al. Diminished Anti-Oxidant Activity of High-Density Lipoprotein-Associated Proteins in Systolic Heart Failure. Circ Heart Fail. 2011;4(1):59–64. DOI: 10.1161/CIRCHEARTFAILURE.110.95834810.1161/CIRCHEARTFAILURE.110.958348302383821062973
    Search in Google Scholar
  35. 35. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation. 2002;106(24):3073–8. DOI: 10.1161/01.CIR.0000041431.57222.AF10.1161/01.CIR.0000041431.57222.AF
    Search in Google Scholar
DOI: https://doi.org/10.1515/rrlm-2015-0039 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 397 - 406
Submitted on: Jun 15, 2015
Accepted on: Sep 22, 2015
Published on: Dec 30, 2015
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
chronic heart failure,
uric acid,
left ventricular function,
oxidative stress,
inflammation
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2015 Adriana Iliesiu, Alexandru Campeanu, Daciana Marta, Irina Parvu, Gabriela Gheorghe, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 23 (2015): Issue 4 (December 2015)Next article